Korro Bio (KRRO) Change in Receivables (2024 - 2026)
Korro Bio (KRRO) posted Change in Receivables of -$969000.0 for Q1 2026, down 750.34% on a QoQ basis from $149000.0 in Q4 2025, and down 525.0% year-over-year from $228000.0 in Q1 2025.
Korro Bio (KRRO) Change in Receivables (2024 - 2026) Analysis & Trends
Korro Bio's Change in Receivables history runs 3 years deep, the most recent figure standing at -$969000.0 for Q1 2026.
- Quarterly Change in Receivables fell 525.0% year-over-year to -$969000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.9 million (down 200.0% YoY) and the FY2025 annual result came in at -$727000.0, down 142.87% from the prior year.
- Change in Receivables was -$969000.0 for Q1 2026 at Korro Bio, down from $149000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $1.7 million in Q4 2024 and bottomed at -$969000.0 in Q1 2026.
- A 3-year average of $0.0 and a median of -$60000.0 in 2025 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2025 — Change in Receivables sank 91.21% — and 2026, when it sank 525.0%.
- Korro Bio's Change in Receivables stood at $1.7 million in 2024, then sank by 91.21% to $149000.0 in 2025, then sank by 750.34% to -$969000.0 in 2026.
- Business Quant data shows KRRO's Change in Receivables at -$969000.0 in Q1 2026, $149000.0 in Q4 2025, and -$269000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | -969,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -969,000.00 |
| Mar 31, 2026 | -969,000.00 |
| Dec 31, 2025 | 149,000.00 |
| Dec 31, 2025 | 149,000.00 |
| Sep 30, 2025 | -269,000.00 |
| Sep 30, 2025 | -269,000.00 |
| Jun 30, 2025 | -835,000.00 |
| Jun 30, 2025 | -835,000.00 |
| Mar 31, 2025 | 228,000.00 |
| Mar 31, 2025 | 228,000.00 |
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2024 | 1.70 Mn |